Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Alfuzosina PH&T*


Contraindicated
Indication only in men

Contraindicated
Indication only in men
Alfuzosina PH&T* :
Type Medicine Non Marketed
Originator Xatral XL
Agent Macromed
Distributor Macromed
Laboratory Midpharma
Responsible Party PH&T SpA
Origin Italy
Manufacturer Mipharm SPA
Manufacturing Type G
Origin Italy
ATC G04CA01

Your comment will appear shortly after approval

Alfuzosina PH&T* :

Revision Date : 30/11/2015


Effect Frequency
Abdominal pain Common
Angina pectoris Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Asthenia Common
Atrial fibrillation Not known
Cephalea Common
Chest pain Uncommon
Cholestasis Not known
Diarrhoea (Diarrhea) Uncommon
Dizziness Common
Dry mouth (Xerostomia) Uncommon
Flushing skin Uncommon
Hepatic damage Not known
Intraoperative floppy iris syndrome Not known
Ischaemic stroke Not known
Lightheadedness Common
Malaise Common
Nasal congestion Uncommon
Nausea Common
Neutropenia Not known
Oedema Uncommon
Orthostatic hypotension Uncommon
Palpitations Uncommon
Priapism Not known
Pruritus Uncommon
Skin Eruption Uncommon
Somnolence Uncommon
Syncope Uncommon
Tachycardia Uncommon
Thrombocytopenia (Thrombopenia) Not known
Urticaria Very rare
Vertigo Uncommon
Vomiting Not known

Different Units By MoH Code

Revision Date : 27/09/2012

Alfuzosina PH&T*  MoH 7876 :
Form Tablet, Prolonged-release
Packaging Blisters
Package Size Box of 30
Strength 10mg
NSSF ✘
Quarantine ✘
Reg. Number 71214/1
Submission date 01/01/2014
Registration Year 2015
Archived Date 03/02/2020


Price Comparison

● Country: Italy
● Package Size: 30
● Medica Comments: Not available in the country of origin
● Pricing Date: 14/10/2019
● Type: Medicine not available

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info